Review



acute lymphoblastic leukemia ccrf-cem  (CEM Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    CEM Corporation acute lymphoblastic leukemia ccrf-cem
    Acute Lymphoblastic Leukemia Ccrf Cem, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/acute lymphoblastic leukemia ccrf-cem/product/CEM Corporation
    Average 90 stars, based on 1 article reviews
    acute lymphoblastic leukemia ccrf-cem - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    acute t lymphoblastic leukemia cell lines ccrf cem  (ATCC)
    96
    ATCC acute t lymphoblastic leukemia cell lines ccrf cem
    Acute T Lymphoblastic Leukemia Cell Lines Ccrf Cem, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/acute t lymphoblastic leukemia cell lines ccrf cem/product/ATCC
    Average 96 stars, based on 1 article reviews
    acute t lymphoblastic leukemia cell lines ccrf cem - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    acute lymphoblastic leukemia ccrf-cem  (CEM Corporation)
    90
    CEM Corporation acute lymphoblastic leukemia ccrf-cem
    Acute Lymphoblastic Leukemia Ccrf Cem, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/acute lymphoblastic leukemia ccrf-cem/product/CEM Corporation
    Average 90 stars, based on 1 article reviews
    acute lymphoblastic leukemia ccrf-cem - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    bcma- acute lymphoblastic leukemia cell line ccrf-cem  (Pasteur Institute)
    90
    Pasteur Institute bcma- acute lymphoblastic leukemia cell line ccrf-cem
    High cytotoxicity of <t>anti-BCMA</t> CAR LRF-NK and PB-NK cells against BCMA-expressing cells. ( A ) Flow cytometric analysis depicts CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) post-co-culture <t>with</t> <t>U266-B1</t> cells (BCMA + cells). ( B ) the mean percentage of CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) after co-culture with CCRF-CEM (BCMA − cells) and K562 cell lines. ( C ) Statistical analysis indicates significantly elevated CD107a expression on anti-BCMA CAR LRF- and PB-NK cells when co-cultured with U266-B1 compared to CCRF-CEM and K562 cells. No significant difference in CD107a expression exists between anti-BCMA CAR LRF- and PB-NK cells. Data presented as Mean ± SD. (** Represents P < 0.001, and *** P < 0.0001, N = 3). LRF: Leukocyte reduction filter. PB: peripheral blood.
    Bcma Acute Lymphoblastic Leukemia Cell Line Ccrf Cem, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bcma- acute lymphoblastic leukemia cell line ccrf-cem/product/Pasteur Institute
    Average 90 stars, based on 1 article reviews
    bcma- acute lymphoblastic leukemia cell line ccrf-cem - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    acute lymphoblastic leukemia  (ATCC)
    96
    ATCC acute lymphoblastic leukemia
    High cytotoxicity of <t>anti-BCMA</t> CAR LRF-NK and PB-NK cells against BCMA-expressing cells. ( A ) Flow cytometric analysis depicts CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) post-co-culture <t>with</t> <t>U266-B1</t> cells (BCMA + cells). ( B ) the mean percentage of CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) after co-culture with CCRF-CEM (BCMA − cells) and K562 cell lines. ( C ) Statistical analysis indicates significantly elevated CD107a expression on anti-BCMA CAR LRF- and PB-NK cells when co-cultured with U266-B1 compared to CCRF-CEM and K562 cells. No significant difference in CD107a expression exists between anti-BCMA CAR LRF- and PB-NK cells. Data presented as Mean ± SD. (** Represents P < 0.001, and *** P < 0.0001, N = 3). LRF: Leukocyte reduction filter. PB: peripheral blood.
    Acute Lymphoblastic Leukemia, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/acute lymphoblastic leukemia/product/ATCC
    Average 96 stars, based on 1 article reviews
    acute lymphoblastic leukemia - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    ccrf cem t cell acute lymphoblastic leukemia all  (DSMZ)
    94
    DSMZ ccrf cem t cell acute lymphoblastic leukemia all
    High cytotoxicity of <t>anti-BCMA</t> CAR LRF-NK and PB-NK cells against BCMA-expressing cells. ( A ) Flow cytometric analysis depicts CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) post-co-culture <t>with</t> <t>U266-B1</t> cells (BCMA + cells). ( B ) the mean percentage of CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) after co-culture with CCRF-CEM (BCMA − cells) and K562 cell lines. ( C ) Statistical analysis indicates significantly elevated CD107a expression on anti-BCMA CAR LRF- and PB-NK cells when co-cultured with U266-B1 compared to CCRF-CEM and K562 cells. No significant difference in CD107a expression exists between anti-BCMA CAR LRF- and PB-NK cells. Data presented as Mean ± SD. (** Represents P < 0.001, and *** P < 0.0001, N = 3). LRF: Leukocyte reduction filter. PB: peripheral blood.
    Ccrf Cem T Cell Acute Lymphoblastic Leukemia All, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ccrf cem t cell acute lymphoblastic leukemia all/product/DSMZ
    Average 94 stars, based on 1 article reviews
    ccrf cem t cell acute lymphoblastic leukemia all - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    t cell acute lymphoblastic leukemia cell line ccrf-cem  (CEM Corporation)
    90
    CEM Corporation t cell acute lymphoblastic leukemia cell line ccrf-cem
    High cytotoxicity of <t>anti-BCMA</t> CAR LRF-NK and PB-NK cells against BCMA-expressing cells. ( A ) Flow cytometric analysis depicts CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) post-co-culture <t>with</t> <t>U266-B1</t> cells (BCMA + cells). ( B ) the mean percentage of CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) after co-culture with CCRF-CEM (BCMA − cells) and K562 cell lines. ( C ) Statistical analysis indicates significantly elevated CD107a expression on anti-BCMA CAR LRF- and PB-NK cells when co-cultured with U266-B1 compared to CCRF-CEM and K562 cells. No significant difference in CD107a expression exists between anti-BCMA CAR LRF- and PB-NK cells. Data presented as Mean ± SD. (** Represents P < 0.001, and *** P < 0.0001, N = 3). LRF: Leukocyte reduction filter. PB: peripheral blood.
    T Cell Acute Lymphoblastic Leukemia Cell Line Ccrf Cem, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/t cell acute lymphoblastic leukemia cell line ccrf-cem/product/CEM Corporation
    Average 90 stars, based on 1 article reviews
    t cell acute lymphoblastic leukemia cell line ccrf-cem - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    t-cell acute lymphoblastic leukemia cell lines (jurkat and ccrf-cem)  (CEM Corporation)
    90
    CEM Corporation t-cell acute lymphoblastic leukemia cell lines (jurkat and ccrf-cem)
    High cytotoxicity of <t>anti-BCMA</t> CAR LRF-NK and PB-NK cells against BCMA-expressing cells. ( A ) Flow cytometric analysis depicts CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) post-co-culture <t>with</t> <t>U266-B1</t> cells (BCMA + cells). ( B ) the mean percentage of CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) after co-culture with CCRF-CEM (BCMA − cells) and K562 cell lines. ( C ) Statistical analysis indicates significantly elevated CD107a expression on anti-BCMA CAR LRF- and PB-NK cells when co-cultured with U266-B1 compared to CCRF-CEM and K562 cells. No significant difference in CD107a expression exists between anti-BCMA CAR LRF- and PB-NK cells. Data presented as Mean ± SD. (** Represents P < 0.001, and *** P < 0.0001, N = 3). LRF: Leukocyte reduction filter. PB: peripheral blood.
    T Cell Acute Lymphoblastic Leukemia Cell Lines (Jurkat And Ccrf Cem), supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/t-cell acute lymphoblastic leukemia cell lines (jurkat and ccrf-cem)/product/CEM Corporation
    Average 90 stars, based on 1 article reviews
    t-cell acute lymphoblastic leukemia cell lines (jurkat and ccrf-cem) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    High cytotoxicity of anti-BCMA CAR LRF-NK and PB-NK cells against BCMA-expressing cells. ( A ) Flow cytometric analysis depicts CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) post-co-culture with U266-B1 cells (BCMA + cells). ( B ) the mean percentage of CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) after co-culture with CCRF-CEM (BCMA − cells) and K562 cell lines. ( C ) Statistical analysis indicates significantly elevated CD107a expression on anti-BCMA CAR LRF- and PB-NK cells when co-cultured with U266-B1 compared to CCRF-CEM and K562 cells. No significant difference in CD107a expression exists between anti-BCMA CAR LRF- and PB-NK cells. Data presented as Mean ± SD. (** Represents P < 0.001, and *** P < 0.0001, N = 3). LRF: Leukocyte reduction filter. PB: peripheral blood.

    Journal: Scientific Reports

    Article Title: Leukoreduction filter derived NK cells offer a promising source for off the shelf CAR NK cell immunotherapy

    doi: 10.1038/s41598-025-97584-1

    Figure Lengend Snippet: High cytotoxicity of anti-BCMA CAR LRF-NK and PB-NK cells against BCMA-expressing cells. ( A ) Flow cytometric analysis depicts CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) post-co-culture with U266-B1 cells (BCMA + cells). ( B ) the mean percentage of CD107a expression on anti-BCMA CAR LRF-NK cells (GFP + population) after co-culture with CCRF-CEM (BCMA − cells) and K562 cell lines. ( C ) Statistical analysis indicates significantly elevated CD107a expression on anti-BCMA CAR LRF- and PB-NK cells when co-cultured with U266-B1 compared to CCRF-CEM and K562 cells. No significant difference in CD107a expression exists between anti-BCMA CAR LRF- and PB-NK cells. Data presented as Mean ± SD. (** Represents P < 0.001, and *** P < 0.0001, N = 3). LRF: Leukocyte reduction filter. PB: peripheral blood.

    Article Snippet: The human BCMA + multiple myeloma cell line (U266-B1), BCMA- acute lymphoblastic leukemia cell line (CCRF-CEM), human erythroleukemic cell line (K562), and human embryonic kidney cell line (HEK293T) were procured from the Pasteur Institute (Tehran, Iran).

    Techniques: Expressing, Co-Culture Assay, Cell Culture

    Specific activation of transduced NK cells. ( A ) The baseline expression levels of CD69 (upper left) on anti-BCMA CAR LRF-NK cells, when cultured alone and CD69 expression following the co-cultivation of anti-BCMA CAR LRF-NK cells with U266-B1 (upper right) CCRF-CEM (Lower Left) and K562 (lower left) cell lines. ( B ) The mean percentage of CD69 as an early activation marker significantly increased on anti-BCMA CAR LRF/PB cells following co-cultivation with the U266-B1 compared to CCRF-CEM cell lines.

    Journal: Scientific Reports

    Article Title: Leukoreduction filter derived NK cells offer a promising source for off the shelf CAR NK cell immunotherapy

    doi: 10.1038/s41598-025-97584-1

    Figure Lengend Snippet: Specific activation of transduced NK cells. ( A ) The baseline expression levels of CD69 (upper left) on anti-BCMA CAR LRF-NK cells, when cultured alone and CD69 expression following the co-cultivation of anti-BCMA CAR LRF-NK cells with U266-B1 (upper right) CCRF-CEM (Lower Left) and K562 (lower left) cell lines. ( B ) The mean percentage of CD69 as an early activation marker significantly increased on anti-BCMA CAR LRF/PB cells following co-cultivation with the U266-B1 compared to CCRF-CEM cell lines.

    Article Snippet: The human BCMA + multiple myeloma cell line (U266-B1), BCMA- acute lymphoblastic leukemia cell line (CCRF-CEM), human erythroleukemic cell line (K562), and human embryonic kidney cell line (HEK293T) were procured from the Pasteur Institute (Tehran, Iran).

    Techniques: Activation Assay, Expressing, Cell Culture, Marker

    mRNA expression of IFN-γ ( A ) and granzyme B ( B ) in anti-BCMA CAR LRF-NK and PB-NK cells following co-culture with U266-B1 (BCMA + ), CCRF-CEM (BCMA − ), and K562 Cell Lines. The augmented expression of IFN-γ and granzyme B was evident in LRF-NK and PB-NK cells after co-cultivation with the K562 cell line, as opposed to their counterparts co-cultivated with U266-B1 and CCRF-CEM cell lines, as well as IL-2 treated NK cells. No statistically significant distinctions were discerned between LRF-NK and PB-NK cells. Conversely, Anti-BCMA CAR NK cells demonstrated a notable increase in the expression of IFN-γ and GrB after co-culture with U266-B1 compared to CCRF-CEM. The absence of significant differences between LRF and PB CAR NK cells in IFN-γ and GrB expression under identical conditions is noteworthy. Notably, a significantly heightened expression of IFN-γ and GrB in CAR NK cells compared to regular NK cells was observed after co-culture with U266-B1 cells. Data are presented as mean ± SD. (Double asterisks (**) signify P < 0.001, and triple asterisks (***) denote P < 0.0001; N = 3). LRF: leukocyte reduction filter. PB: peripheral blood.

    Journal: Scientific Reports

    Article Title: Leukoreduction filter derived NK cells offer a promising source for off the shelf CAR NK cell immunotherapy

    doi: 10.1038/s41598-025-97584-1

    Figure Lengend Snippet: mRNA expression of IFN-γ ( A ) and granzyme B ( B ) in anti-BCMA CAR LRF-NK and PB-NK cells following co-culture with U266-B1 (BCMA + ), CCRF-CEM (BCMA − ), and K562 Cell Lines. The augmented expression of IFN-γ and granzyme B was evident in LRF-NK and PB-NK cells after co-cultivation with the K562 cell line, as opposed to their counterparts co-cultivated with U266-B1 and CCRF-CEM cell lines, as well as IL-2 treated NK cells. No statistically significant distinctions were discerned between LRF-NK and PB-NK cells. Conversely, Anti-BCMA CAR NK cells demonstrated a notable increase in the expression of IFN-γ and GrB after co-culture with U266-B1 compared to CCRF-CEM. The absence of significant differences between LRF and PB CAR NK cells in IFN-γ and GrB expression under identical conditions is noteworthy. Notably, a significantly heightened expression of IFN-γ and GrB in CAR NK cells compared to regular NK cells was observed after co-culture with U266-B1 cells. Data are presented as mean ± SD. (Double asterisks (**) signify P < 0.001, and triple asterisks (***) denote P < 0.0001; N = 3). LRF: leukocyte reduction filter. PB: peripheral blood.

    Article Snippet: The human BCMA + multiple myeloma cell line (U266-B1), BCMA- acute lymphoblastic leukemia cell line (CCRF-CEM), human erythroleukemic cell line (K562), and human embryonic kidney cell line (HEK293T) were procured from the Pasteur Institute (Tehran, Iran).

    Techniques: Expressing, Co-Culture Assay